GRM6
Basic information
Region (hg38): 5:178977587-178996206
Links
Phenotypes
GenCC
Source:
- congenital stationary night blindness 1B (Definitive), mode of inheritance: AR
- congenital stationary night blindness 1B (Definitive), mode of inheritance: AR
- congenital stationary night blindness 1B (Strong), mode of inheritance: AR
- congenital stationary night blindness (Supportive), mode of inheritance: AD
- congenital stationary night blindness 1B (Strong), mode of inheritance: AR
- GRM6-related retinopathy (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Night blindness, congenital stationary, type 1B | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Ophthalmologic | 11874764; 15781871; 16249515; 16622103; 22008250 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (39 variants)
- Congenital stationary night blindness 1B (5 variants)
- Congenital stationary night blindness (2 variants)
- Leber congenital amaurosis (1 variants)
- Retinal dystrophy (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GRM6 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 202 | 24 | 229 | |||
missense | 355 | 16 | 12 | 389 | ||
nonsense | 17 | 19 | ||||
start loss | 1 | |||||
frameshift | 19 | 22 | ||||
inframe indel | 11 | 12 | ||||
splice donor/acceptor (+/-2bp) | 4 | |||||
splice region | 8 | 14 | 3 | 25 | ||
non coding | 49 | 33 | 82 | |||
Total | 40 | 12 | 369 | 268 | 69 |
Highest pathogenic variant AF is 0.000158
Variants in GRM6
This is a list of pathogenic ClinVar variants found in the GRM6 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-178981486-T-C | Likely benign (Aug 28, 2020) | |||
5-178981529-C-T | Likely benign (Aug 28, 2020) | |||
5-178981543-G-C | Likely benign (Aug 28, 2020) | |||
5-178981663-G-A | Likely benign (Jul 10, 2023) | |||
5-178981667-G-T | Retinal dystrophy • Inborn genetic diseases | Conflicting classifications of pathogenicity (Jan 18, 2024) | ||
5-178981675-A-G | Likely benign (Mar 16, 2020) | |||
5-178981680-C-T | Uncertain significance (Jul 10, 2023) | |||
5-178981681-G-A | Conflicting classifications of pathogenicity (Jan 19, 2024) | |||
5-178981682-C-T | Uncertain significance (Sep 13, 2022) | |||
5-178981684-C-T | Likely benign (-) | |||
5-178981688-G-C | Inborn genetic diseases | Uncertain significance (Jan 23, 2024) | ||
5-178981690-T-C | Likely benign (Nov 11, 2022) | |||
5-178981701-C-T | Uncertain significance (Jul 19, 2022) | |||
5-178981702-C-T | Likely benign (Dec 02, 2022) | |||
5-178981703-G-A | GRM6-related disorder | Likely benign (Nov 27, 2023) | ||
5-178981705-G-A | Likely benign (Jan 15, 2024) | |||
5-178981710-T-G | Uncertain significance (Mar 03, 2021) | |||
5-178981711-G-A | Likely benign (Dec 16, 2022) | |||
5-178981713-C-A | Uncertain significance (Jun 02, 2021) | |||
5-178981717-G-A | Likely benign (Jan 07, 2024) | |||
5-178981724-C-T | Uncertain significance (Sep 27, 2022) | |||
5-178981725-G-A | Inborn genetic diseases | Uncertain significance (Feb 17, 2024) | ||
5-178981730-C-T | Uncertain significance (Aug 16, 2022) | |||
5-178981742-T-G | Uncertain significance (Aug 22, 2022) | |||
5-178981761-G-C | Uncertain significance (Dec 20, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GRM6 | protein_coding | protein_coding | ENST00000231188 | 10 | 17880 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.46e-17 | 0.0423 | 125557 | 1 | 190 | 125748 | 0.000760 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.512 | 534 | 502 | 1.06 | 0.0000340 | 5512 |
Missense in Polyphen | 212 | 203.27 | 1.0429 | 2288 | ||
Synonymous | -0.887 | 236 | 219 | 1.08 | 0.0000161 | 1885 |
Loss of Function | 0.778 | 28 | 32.8 | 0.853 | 0.00000173 | 332 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00101 | 0.00101 |
Ashkenazi Jewish | 0.000299 | 0.000298 |
East Asian | 0.000438 | 0.000435 |
Finnish | 0.00130 | 0.00129 |
European (Non-Finnish) | 0.000690 | 0.000686 |
Middle Eastern | 0.000438 | 0.000435 |
South Asian | 0.00141 | 0.00141 |
Other | 0.000985 | 0.000978 |
dbNSFP
Source:
- Function
- FUNCTION: G-protein coupled receptor for glutamate. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling inhibits adenylate cyclase activity (By similarity). Signaling stimulates TRPM1 channel activity and Ca(2+) uptake. Required for normal vision. {ECO:0000250, ECO:0000269|PubMed:23452348}.;
- Pathway
- Glutamatergic synapse - Homo sapiens (human);Phospholipase D signaling pathway - Homo sapiens (human);Neuroactive ligand-receptor interaction - Homo sapiens (human);GPCRs, Class C Metabotropic glutamate, pheromone;Signaling by GPCR;Signal Transduction;GPCR signaling-G alpha q;GPCR signaling-cholera toxin;GPCR signaling-pertussis toxin;Class C/3 (Metabotropic glutamate/pheromone receptors);GPCR ligand binding;GPCR signaling-G alpha s Epac and ERK;GPCR signaling-G alpha s PKA and ERK;G alpha (i) signalling events;GPCR signaling-G alpha i;GPCR downstream signalling
(Consensus)
Intolerance Scores
- loftool
- 0.0620
- rvis_EVS
- -1.32
- rvis_percentile_EVS
- 4.79
Haploinsufficiency Scores
- pHI
- 0.285
- hipred
- N
- hipred_score
- 0.275
- ghis
- 0.392
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.105
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Grm6
- Phenotype
- vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Zebrafish Information Network
- Gene name
- grm6b
- Affected structure
- retina
- Phenotype tag
- abnormal
- Phenotype quality
- decreased functionality
Gene ontology
- Biological process
- G protein-coupled receptor signaling pathway;adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway;G protein-coupled glutamate receptor signaling pathway;detection of visible light;detection of light stimulus involved in visual perception;regulation of synaptic transmission, glutamatergic;positive regulation of calcium ion import
- Cellular component
- Golgi membrane;endoplasmic reticulum membrane;plasma membrane;integral component of plasma membrane;dendrite;presynaptic membrane
- Molecular function
- G protein-coupled receptor activity;protein binding;glutamate receptor activity;protein homodimerization activity